The financially motivated cybercriminal threat actor Storm-1175 operates high-velocity ransomware campaigns that weaponize ...

These days, it seems like every tech company and their corporate parent is looking to squeeze AI tools and features into ...

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...